ABVC
ABVC BioPharma Inc

3,461
Loading...
Loading...
News
all
press releases
ABVC BioPharma Releases Corporate Presentation Update
An announcement from ABVC BioPharma, Inc. (ABVC) is now available. ABVC BioPharma, Inc. has recently updated its corporate presentation, details of...
TipRanks Financial Blog·1y ago
News Placeholder
More News
News Placeholder
ABVC BioPharma Corrects Licensing Deal Financials
ABVC BioPharma, Inc. (ABVC) has issued an update. ABVC BioPharma has announced corrections to a previous press release concerning their licensing d...
TipRanks Financial Blog·1y ago
News Placeholder
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection PR Newswire VANCOUVER, BC, May...
PR Newswire·1y ago
News Placeholder
Short Interest in ABVC BioPharma, Inc. (NASDAQ:ABVC) Declines By 30.0%
ABVC BioPharma, Inc. (NASDAQ:ABVC Get Free Report) was the recipient of a significant decrease in short interest during the month of March. As of March 15th, there was short interest...
Zolmax·1y ago
News Placeholder
Why ABVC BioPharma Stock Is Up Today
ABVC BioPharma said that the licensing agreement includes the ophthalmology pipeline, including the medical device Vitargus licensed products' and clinical trial, registration, manufacturing, supply...
Benzinga·1y ago
News Placeholder
ABVC BioPharma enters into global licensing deal with ForSeeCon Eye
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
News Placeholder
ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
FREMONT, CA, March 26, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in...
Globe Newswire·1y ago
News Placeholder
AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars
FREMONT, CA, March 21, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in...
Globe Newswire·1y ago
News Placeholder
ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine
FREMONT, CA, March 19, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in...
Globe Newswire·1y ago
News Placeholder
ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
FREMONT, CA, March 14, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) ( Company ), a biotechnology company specializing in botanically based solutions that deliver...
Globe Newswire·1y ago

Latest ABVC News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.